Telix Pharmaceuticals Limited (TLX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    10.28
    0.06 (0.59%)
    At close: Oct 03, 2025, 3:59 PM
    10.07
    -2.04%
    Pre-market: Oct 06, 2025, 09:25 AM EDT

    Telix Pharmaceuticals Cash Flow Statement

    Financials in AUD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 -15.16M n/a 31.21M 5.21M -47.51M -104.08M -118.89M -80.51M -59.1M
    Depreciation & Amortization
    		 12.57M n/a 5.63M 6.92M 5.94M 5.4M 5.37M 5.44M 5.36M
    Stock-Based Compensation
    		 17.6M n/a 7.47M 8.79M 7.16M 8.11M 1.5M 1.32M 2.88M
    Other Working Capital
    		 -64.27M -64.27M -20.52M -20.52M -3.69M -3.69M 2.6M 2.6M -193K
    Other Non-Cash Items
    		 80.18M 103.2M 16.04M 25.6M 62.96M 45.51M 33.35M 26.63M 56.25M
    Deferred Income Tax
    		 n/a n/a 42.78M 42.78M 16.89M 16.89M 5.52M 5.52M -5.46M
    Change in Working Capital
    		 -64.27M -64.27M -57.53M -57.53M -28.64M -28.64M -7.42M -7.42M -612K
    Operating Cash Flow
    		 30.92M 38.93M 45.6M 23.88M 9.51M -63.97M -90.9M -59.33M -8.22M
    Capital Expenditures
    		 -30.47M -34.03M -21.48M -10.79M -7.67M -13.86M -10.2M -1.34M -454K
    Cash Acquisitions
    		 -360.47M -34.69M -23.31M n/a -850K -973K n/a n/a -322K
    Purchase of Investments
    		 -51.99M -51.99M -13.15M -13.15M n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 -59.41M -33.95M -10.28M -1.54M -25K -2.16M -3.08M -1.39M -449K
    Investing Cash Flow
    		 -482.63M -134.95M -68.23M -25.49M -8.55M -17M -13.28M -2.73M -1.23M
    Debt Repayment
    		 647.34M 654.31M 2.14M 639.28K n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -17.47M -16.39M 6.59M 9.18M 8.49M 174.96M 173.68M 2.85M 33.97M
    Financial Cash Flow
    		 630.86M 638.92M 9.1M 10.19M 8.49M 174.96M 173.68M 2.85M 33.97M
    Net Cash Flow
    		 906.26M 587.64M -12.36M 6.91M 9.12M 94.29M 72.99M -55.91M 25.24M
    Free Cash Flow
    		 5.92M 9M 22.75M 13.09M 1.83M -77.83M -101.1M -60.67M -8.67M

    Add to Watchlist